Tag: CGMs
GEMCORE: ‘We want to surround the patient with product’
July 8, 2022Liz Beaulieu, Editor
HUDSON, Ohio – GEMCORE marks its 30th year in business in 2022, celebrating everything from its humble beginnings to its diversification.
The company, which was founded in the family home of Ed and Toni Edwards, has grown to comprise a group of businesses and that spans a 130,000-square-foot headquarters and seven branch locations.
“My dad was a health care operations and logistics executive, and my mom was an ICU nurse,” said Matt Edwards, CEO. “I learned...
In brief: Medtrade location, Quipt expansion, CGM access
June 24, 2022HME News Staff
ATLANTA – Medtrade will take place March 28-30 in Dallas next year, show organizers have announced.
The event will take place at the Kay Bailey Hutchinson Convention Center in the Convention Center District in downtown Dallas.
“Switching to one show per year was motivated by feedback from attendees and exhibitors,” said York Schwab, show director, in today’s Medtrade Monday. “Moving the show to Dallas is part of the same equation. Dallas is centrally...
TRICARE expands access to CGMs
June 20, 2022HME News Staff
FALLS CHURCH, Va. – The TRICARE pharmacy benefit now covers two brands of continuous glucose monitors (CGMs): the Abbott FreeStyle Libre 2 and the Dexcom G6. Previously, CGMs were only available as DME under the TRICARE medical benefit. They will also continue to be covered under the medical benefit. “This change in expanded coverage will improve access for patients to get the CGMs they need,” said Edward VonBerg, PharmD, chief of the Defense Health Agency’s Formulary Management...
Abbott receives FDA clearance for FreeStyle Libre 3
June 1, 2022HME News Staff
ABBOTT PARK, Ill. – Abbott has received clearance from the U.S. Food and Drug Administration for its FreeStyle Libre 3 system for people with diabetes age four and up. "The FreeStyle Libre 3 system is a direct result of listening to our customers – and giving them the innovation and sensing technology they've been looking for," said Jared Watkin, senior vice president of Abbott's diabetes care business. "It's a game changer for the millions of people living with diabetes....
CGM technology drives diabetes market
April 2, 2022John Andrews
As the diabetes market observes the 100th anniversary of insulin therapy, manufacturers are optimistic about the growth of medical technology in the category. Specifically, the evolution of continuous glucose meters has charted a path forward for the industry to follow, they say.
Elaine Anderson, head of the Eversense CGM business unit at Parsippany, N.J.-based Ascensia Diabetes Care, calls CGM the “first step change” in diabetes treatment since the “transformative discovery”...
Abbott Freestyle Libre receives expanded coverage in Japan
March 30, 2022HME News Staff
ABBOTT PARK, Ill. – Abbott has received approval from the Japanese Ministry of Health, Labour and Welfare for expansion of reimbursement coverage for its FreeStyle Libre system to include all people with diabetes who use insulin at least once a day. The expanded coverage will enable more people with diabetes to access the glucose data needed to manage their condition without the routine fingersticks associated with traditional blood glucose monitoring. "The best health care solution is the...
Reporter’s Notebook: CGM market growing, creating opportunities
February 28, 2022Theresa Flaherty, Managing Editor
When CMS paved the way for coverage of continuous blood glucose monitors (CGMs), it was a shot in the arm for a diabetes market devastated by the competitive bidding program. In the years since, the market has exploded and it shows no signs of slowing down.
In 2020, Medicare spending for CGMs (K0554) was $21,594,764, compared to approximately $4,192,820 in 2017, the year CMS began paying for the devices, according to the HME Databank.
The top provider in 2020: North Coast Medical...
Advanced Diabetes sees complement in US MED
August 20, 2021Theresa Flaherty, Managing Editor
CARLSBAD, Calif. – Advanced Diabetes Supply increases its visibility in the eastern U.S. and gains a large platform on which to grow with its recent acquisition of US Medical Supply (US MED).
“Both companies have a good brand, and they really complement each other,” said Tim Cady, president of ADS. “Our immediate plan, short term, is to keep both brands out there.”
ADS’s focus on insulin pumps and continuous glucose monitors – a shift forced...
Lawmakers urge VA to drop finger stick requirement
August 20, 2021HME News Staff
WASHINGTON – Sens. Jeanne Shaheen, D-N.H., and Susan Collins, R-Maine, along with Reps. Diana DeGette, D-Colo., and Tom Reed, R-NY., Co-Chairs of the Senate and Congressional Diabetes Caucuses, sent a letter to Secretary of Veterans Affairs Denis McDonough urging the VA to stop requiring veterans to use the medically unnecessary four finger stick tests prior to initiating continuous glucose monitoring (CGM) therapy.
In their letter, the lawmakers highlighted...
Diabetes consolidation continues: Advanced Diabetes acquires US MED
July 28, 2021HME News Staff
CARLSBAD, Calif. – Advanced Diabetes Supply has acquired US Medical Supply (US MED), a portfolio company of H.I.G. Capital that provides continuous glucose monitors and medical supplies.
Founded in 1996, the Doral, Fla.-based US MED contracts with more than 500 insurance plans covering nearly 200 million lives. It was acquired by H.I.G in 2015.
“H.I.G. served as a value-added partner to our leadership team and supported the transformation of the business,” said...